Synergy between efflux pump CmeABC and modifications in ribosomal proteins L4 and L22 in conferring macrolide resistance in Campylobacter jejuni and Campylobacter coli

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3893-3896

  Cagliero, Cédric ^a   Mouline, Christian ^a   Cloeckaert, Axel ^a   Payot, Sophie ^a  

^a UR1282   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; CIPROFLOXACIN; CMEABC TRANSPORTER; ERYTHROMYCIN; RIBOSOME PROTEIN; RIBOSOME PROTEIN L22; RIBOSOME PROTEIN L4; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM MUTANT; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MODIFICATION;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; DRUG RESISTANCE, BACTERIAL; MACROLIDES; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 23S;

EID: 33750577739     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00616-06     Document Type: Article

References (18)

1. Boyanova, L., G. Gergova, Z. Spassova, R. Koumanova, P. Yaneva, I. Mitov, S. Derejian, and Z. Krastev. 2004. Campylobacter infection in 682 Bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases. Diagn. Microbiol. Infect. Dis. 49:71-74.
2. Cagliero, C., C. Mouline, S. Payot, and A. Cloeckaert. 2005. Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli. J. Antimicrob. Chemother. 56:948-950.
3. Corcoran, D., T. Quinn, L. Cotter, and S. Fanning. 2006. An investigation of the molecular mechanisms contributing to high-level erythromycin resistance in Campylobacter. Int. J. Antimicrob. Agents 27:40-45.
4. Davydova, N., V. Streltsov, M. Wllce, A. Liljas, and M. Garber. 2002. L22 ribosomal protein and effect of its mutation on ribosome resistance to erythromycin. J. Mol. Biol. 322:635-644.
5. Fouts, D. E., E. F. Mongodin, R. E. Mandrell, W. G. Miller, D. A. Rasko, J. Ravel, L. M. Brinkac, R. T. DeBoy, C. T. Parker, S. C. Daugherty, R. J. Dodson, A. S. Durkin, R. Madupu, S. A. Sullivan, J. U. Shetty, M. A. Ayodeji, A. Shvartsbeyn, M. C. Schatz, J. H. Badger, C. M. Fraser, and K. E. Nelson. 2005. Major structural differences and novel potential virulence mechanisms from the genomes of multiple Campylobacter species. PLoS Biol. 3:e15.
6. Gibreel, A., V. N. Kos, M. Keelan, C. A. Trieber, S. Levesque, S. Midland, and D. E. Taylor. 2005. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob. Agents Chemother. 49:2753-2759.
7. Harms, J., F. Schluenzen, R. Zarivach, A. Bashan, S. Gat, I. Agmon, H. Bartels, F. Franceschi, and A. Yonath. 2001. High resolution structure of the large ribosomal subunit from a mesophilic eubacterium. Cell 107:679-688.
8. Malbruny, B., A. Canu, B. Bozdogan, B. Fantin, V. Zarrouk, S. Dutka-Malen, C. Feger, and R. Leclercq. 2002. Resistance to quinupristin- dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus. Antimicrob. Agents Chemother. 46:2200-2207.
9. Moore, J. E., D. Corcoran, J. S. G. Dooley, S. Fanning, B. Lucey, M. Matsuda, D. A. McDowell, F. Megraud, B. C. Millar, R. O'Mahony, L. O'Riordan, M. O'Rourke, J. R. Rao, P. J. Rooney, A. Sails, and P. Whyte. 2005. Campylobacter. Vet. Res. 36:351-382.
10. Parkhill, J., B. W. Wren, K. Mungall, J. M. Ketley, C. Churcher, D. Basham, T. Chillingworth, R. M. Davies, T. Feltwell, S. Holroyd, K. Jagels, A. V. Karlyshev, S. Moule, M. J. Pallen, C. W. Penn, M. A. Quail, M. A. Rajandream, K. M. Rutherford, A. H. van Vliet, S. Whitehead, and B. G. Barrell. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665-668.
11. Payot, S., J.-M. Bolla, D. Corcoran, S. Fanning, F. Mégraud, and Q. Zhang. 2006. Mechanisms of fluoroquinolone and macrolide resistance in Campylobacter spp. Microbes Infect. 8:1967-1971.
12. Payot, S., A. Cloeckaert, and E. Chaslus-Dancla. 2002. Selection and characterization of fluoroquinolone-resistant mutants of Campylobacter jejuni using enrofloxacin. Microb. Drug Resist. 8:335-343.
13. Peric, M., B. Bozdogan, C. Galderisi, D. Krissinger, T. Rager, and P. C. Appelbaum. 2004. Inability of L22 ribosomal protein alteration to increase macrolide MICs in the absence of efflux mechanism in Haemophilus influenzae HMC-S. J. Antimicrob. Chemother. 54:393-400.
14. Poehlsgaard, J., and S. Douthwaite. 2005. The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. 3:870-881.
15. Rao, D., J. R. Rao, E. Crothers, R. McMullan, D. McDowell, A. McMahon, P. J. Rooney, B. C. Millar, and J. E. Moore. 2005. Increased erythromycin resistance in clinical Campylobacter in Northern Ireland-an update. J. Antimicrob. Chemother. 55:395-396.
16. Roberts, M. C. 2004. Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibiotics. Mol. Biotechnol. 28:47-62.
17. Tenson, T., and A. Mankin. 2006. Antibiotics and the ribosome. Mol. Microbiol. 59:1664-1677.
18. Tu, D., G. Blaha, P. B. Moore, and T. A. Steitz. 2005. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121:257-270.